Table 1.
Clinicopathological features | n (%) | 6-mo OS | Median survival time (mo) | P value |
Gender | 0.923 | |||
Male | 38 (65.2) | 54.7% | 6.6 | |
Female | 23 (34.8) | 59.2% | 6.4 | |
Age (yr) | 0.516 | |||
≥ 60 | 33 (54.1) | 50.4% | 6.5 | |
< 60 | 28 (45.9) | 61.5% | 10.6 | |
Primary tumor | 0.015 | |||
Colorectal | 51 (69.6) | 83.6% | 10.6 | |
Gastric | 10 (30.4) | 16.4% | 1.8 | |
Differentiation | 0.005 | |||
Well + Moderate | 41 (67.2) | 71.5% | 10.9 | |
Poor | 20 (32.8) | 26.5% | 4.1 | |
ECOG | 0.031 | |||
0-1 | 40 (65.6) | 64.4% | 10.6 | |
> 1 | 21 (34.4) | 42.9% | 5.1 | |
Surgical approach | 0.053 | |||
OBS | 31 (50.8) | 44.6% | 5.3 | |
MDS | 30 (49.2) | 68.6% | 10.9 | |
Obstruction | 0.25 | |||
Single | 41 (67.2) | 57% | 6.6 | |
Multiple | 20 (32.8) | 55% | 6.1 | |
Intestinal obstruction | 0.084 | |||
Yes | 31 (50.8) | 53.2% | 6.1 | |
No | 30 (49.2) | 60.1% | 10.9 | |
Colon/rectum obstruction | 0.389 | |||
Yes | 37 (60.7) | 57.4% | 10.9 | |
No | 24 (39.3) | 54.8% | 6.5 | |
Ascites | 0.691 | |||
Yes | 15 (24.6) | 41.1% | 5.1 | |
No | 46 (75.4) | 61.1% | 6.6 | |
Greater omentum metastasis | 0.044 | |||
Yes | 42 (68.9) | 51.2% | 6.1 | |
No | 19 (31.1) | 67.5% | 17.3 | |
Distant metastasis | 0.13 | |||
Yes | 24 (39.3) | 50% | 5.2 | |
No | 37 (60.7) | 60.4% | 10.9 | |
Symptom relief | 0.007 | |||
Yes | 46 (75.4) | 63.7% | 10.9 | |
No | 15 (24.6) | 31.5% | 3.9 |
OBS: Ostomy/by-pass surgery; MDS: Massive debulking surgery; ECOG: Eastern Cooperative Oncology Group; OS: Overall survival.